Goldman Sachs’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-78,300
| Closed | -$5.5M | – | 6003 |
|
|
2022
Q3 | $5.5M | Buy |
+78,300
| New | +$6.14M | ﹤0.01% | 3050 |
|
|
2021
Q3 | – | Sell |
-8,400
| Closed | -$683K | – | 6252 |
|
|
2021
Q2 | $683K | Hold |
8,400
| – | – | ﹤0.01% | 5024 |
|
|
2021
Q1 | $662K | Sell |
8,400
-10,800
| -56% | -$847K | ﹤0.01% | 4908 |
|
|
2020
Q4 | $1.64M | Sell |
19,200
-12,800
| -40% | -$1.06M | ﹤0.01% | 3862 |
|
|
2020
Q3 | $2.47M | Buy |
32,000
+300
| +0.9% | +$22.9K | ﹤0.01% | 3426 |
|
|
2020
Q2 | $2.32M | Sell |
31,700
-43,400
| -58% | -$3.08M | ﹤0.01% | 3354 |
|
|
2020
Q1 | $4.98M | Buy |
75,100
+14,800
| +25% | +$1.04M | ﹤0.01% | 2646 |
|
|
2019
Q4 | $4.15M | Sell |
60,300
-25,700
| -30% | -$1.75M | ﹤0.01% | 3107 |
|
|
2019
Q3 | $6.32M | Sell |
86,000
-37,700
| -30% | -$2.74M | ﹤0.01% | 2683 |
|
|
2019
Q2 | $8.87M | Sell |
123,700
-84,400
| -41% | -$5.99M | ﹤0.01% | 2458 |
|
|
2019
Q1 | $14.3M | Sell |
208,100
-2,900
| -1% | -$187K | ﹤0.01% | 2139 |
|
|
2018
Q4 | $12.6M | Buy |
211,000
+140,100
| +198% | +$8.77M | ﹤0.01% | 2169 |
|
|
2018
Q3 | $4.75M | Sell |
70,900
-104,100
| -59% | -$6.93M | ﹤0.01% | 3023 |
|
|
2018
Q2 | $11.3M | Sell |
175,000
-31,500
| -15% | -$2.06M | ﹤0.01% | 2307 |
|
|
2018
Q1 | $14.8M | Buy |
206,500
+120,100
| +139% | +$8.64M | ﹤0.01% | 2061 |
|
|
2017
Q4 | $6.52M | Sell |
86,400
-218,700
| -72% | -$16M | ﹤0.01% | 2783 |
|
|
2017
Q3 | $22.2M | Sell |
305,100
-213,300
| -41% | -$15.4M | 0.01% | 1896 |
|
|
2017
Q2 | $38.4M | Buy |
518,400
+142,100
| +38% | +$10.6M | 0.01% | 1428 |
|
|
2017
Q1 | $27.5M | Sell |
376,300
-455,600
| -55% | -$31.9M | 0.01% | 1672 |
|
|
2016
Q4 | $54.4M | Buy |
831,900
+143,300
| +21% | +$9.83M | 0.02% | 1204 |
|
|
2016
Q3 | $51.1M | Buy |
688,600
+251,000
| +57% | +$18.6M | 0.02% | 1191 |
|
|
2016
Q2 | $32M | Buy |
437,600
+132,400
| +43% | +$9.43M | 0.01% | 1439 |
|
|
2016
Q1 | $21.6M | Buy |
305,200
+122,700
| +67% | +$8.16M | 0.01% | 1670 |
|
|
2015
Q4 | $12.2M | Sell |
182,500
-108,100
| -37% | -$7.19M | ﹤0.01% | 2102 |
|
|
2015
Q3 | $18.4M | Sell |
290,600
-106,100
| -27% | -$6.93M | 0.01% | 1774 |
|
|
2015
Q2 | $25.9M | Buy |
396,700
+133,800
| +51% | +$9.08M | 0.01% | 1602 |
|
|
2015
Q1 | $18.2M | Buy |
262,900
+37,000
| +16% | +$2.56M | 0.01% | 1826 |
|
|
2014
Q4 | $15.6M | Sell |
225,900
-381,000
| -63% | -$25.7M | ﹤0.01% | 1994 |
|
|
2014
Q3 | $39.6M | Sell |
606,900
-55,800
| -8% | -$3.68M | 0.01% | 1252 |
|
|
2014
Q2 | $45.2M | Buy |
662,700
+508,500
| +330% | +$34.1M | 0.01% | 1179 |
|
|
2014
Q1 | $10M | Sell |
154,200
-249,500
| -62% | -$15.7M | ﹤0.01% | 2364 |
|
|
2013
Q4 | $26.3M | Buy |
403,700
+8,100
| +2% | +$518K | 0.01% | 1530 |
|
|
2013
Q3 | $23.5M | Sell |
395,600
-818,900
| -67% | -$48.5M | 0.01% | 1501 |
|
|
2013
Q2 | $69.6M | Buy |
+1,214,500
| New | +$72.1M | 0.03% | 713 |
|
Other funds holding CL
VCM
DAM
VPM
Goldman Sachs's CL Position: Q1 2026 in Review
Goldman Sachs increased its Colgate-Palmolive (CL) stake by 72% in Q1 2026, buying an estimated $355M and bringing the position to 9,475,834 shares worth $808M. The position accounts for 0.09% of the portfolio, ranked #206.
Goldman Sachs first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $894M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Goldman Sachs held 9,475,834 shares of Colgate-Palmolive worth $808M as of Q1 2026.
- Goldman Sachs bought 3,982,104 Colgate-Palmolive shares in Q1 2026, an estimated $355M.
- Colgate-Palmolive made up 0.09% of Goldman Sachs's portfolio in Q1 2026, its #206 holding.
- Goldman Sachs first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Colgate-Palmolive position peaked at $894M in Q3 2024.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.